-
-
-
-
-
-
-
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
4 themes and 4 key biotech stocks for 2025: Jefferies
-
-
-
-
-
-
-
Vaxcyte (PCVX) Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Vaxcyte, Inc (PCVX) Prices 10.94M Share and Warrant Offering at $64/sh
-
-
-
-
-
-
-
Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Vaxcyte (PCVX) PT Raised to $56 at Jefferies
-
74,354 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


